Subsequent to December 31, 2020, convertible notes and accrued in interest aggregating $38,714,000 were converted into 11,386,435 shares of common stock at conversion prices. Of this amount $35,660,000 was principal and accrued interest as of December 31, 2020. The remaining $3,054,000 was principal, and accrued interest subsequent to December 31, 2020

Subsequent to December 31, 2020, the Company issued 4,945,000 shares of its common stock to investors for net cash proceeds of $24,882,000 pursuant to our February 2021 Offering Circular.

Subsequent to December 31, 2020, the Company issued 660,545 shares of common stock upon exercise of warrants for cash proceeds of $3,200,000.

The following unaudited proforma information are based on the Company’s historical financial statements as of December 31, 2020 after giving effect to the subsequent conversion notes payable to equity and sale of common shares for cash.

Subsequent to December 31, 2020, the Company issued 5,491,638 shares of common stock with a fair value of $34,762,000 to officers and directors as incentive for the completion of our February 2021 Offering Circular.

Subsequent to December 31, 2020, the Company issued convertible notes payable in the aggregate of $1,205,000 in exchange for cash. The Company also issued notes payable of $545,000 in exchange for consulting services. In addition, accrued expenses of $525,000 from a related party that was recorded as of December 31, 2020 (Note 12) was cancelled in exchange for a convertible note payable. The Company is currently in the process of determining the appropriate accounting for these notes payable totaling $2,275,000.